https://t.co/QKp0ppiYMz
What a phenomenal tour de force this multicentre study will be. A real testament to integrated research efforts in the UK. Huge congratulations to all those who have worked so hard to bring it to this point.
Immunotherapy saved my life. Can research improve the odds for others? https://t.co/TeVVsXcSky
Always so wonderful to hear the impact of years of dedicated and thoughtful research on the individual patient.
Privileged to watch this rising super 🌟@CSpencer_path excel at her PhD seminar. Huge future in computational path 🔬! Fantastic collaborator, colleague & most importantly friend!
Congrats Charlotte, PhDone ✅🎉🙌🏾! @TurajlicLab @TheCrick@royalmarsdenNHS
It’s always super rewarding to see a young ambitious scientist develop & shine 💫! #ECR 👩🏻🔬
It’s been a joy brainstorming ideas & working with Maitane with @Barbara_Ibarzo @TurajlicLab @TheCrick. Thanks @EACRnews for enabling opportunities like these! 🇪🇸🤝🇬🇧
World's first jab to stop skin cancer brings hope for patients @theipaper
Dr Heather Shaw, national co-ordinating investigator of the trial, says the jab is being tested to see if it can work for lung, bladder and kidney cancer as well
https://t.co/Nq2C1FG7DX
🇬🇧 World's First Jab To Stop Skin Cancer Brings Hope For Patients
▫Dr Heather Shaw says the jab is being tested to see if it can work for lung, bladder and kidney cancer
▫@PMGallagher1
▫https://t.co/akdTi3ZDg5 👈
#frontpagestoday#UK@theipaper 🇬🇧
Day 3 #ikcseu24 starting with molecular mechanism of RCC w @TurajlicLab immunotherapy resistance @BraunMDPhD & translating computational pathology>treatment @CSpencer_path
@ZaydTippu applying lessons learned from TracerX RCC @TurajlicLab with respect to evolutionary patterns in RCC in order to understand risk of recurrence after nephrectomy #IKCSEU24@KidneyCancer
An outstanding and comprehensive overview of chromophobe RCC biology by @MVossMD#IKCSEU24. Please see the recent review for more discussion on the biology of this tumor type in @Cancer_Cell https://t.co/eC99aihfzW
@KidneyCancer
Great to be here at IKCS to hear from the leaders in kidney cancer about how we address the most pressing clinical needs our patients. @TurajlicLab @KidneyCancer@TheCrick
Thrilled to be at #AACR24 with @DrJonLim presenting his poster on how dendritic cells shape cancer immunity winning the scholar in training award. @AACR @TurajlicLab @TheCrick